Literature DB >> 32433106

CORR Insights®: What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?

Takeshi Morii1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32433106      PMCID： PMC7594909          DOI： 10.1097/CORR.0000000000001321

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  8 in total

1.  Clear cell chondrosarcoma: Cytologic findings in six cases.

Authors:  Xiaoyin Sara Jiang; Liron Pantanowitz; Marilyn M Bui; Robert Esther; Debra Budwit; Leslie G Dodd
Journal:  Diagn Cytopathol       Date:  2013-10-25       Impact factor: 1.582

2.  The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.

Authors:  Marilyn Heng; Abha Gupta; Peter W Chung; John H Healey; Max Vaynrub; Peter S Rose; Matthew T Houdek; Patrick P Lin; Andrew J Bishop; Francis J Hornicek; Yen-Lin Chen; Santiago Lozano-Calderon; Ginger E Holt; Ilkyu Han; David Biau; Xiaohui Niu; Nicholas M Bernthal; Peter C Ferguson; Jay S Wunder
Journal:  Eur J Cancer       Date:  2019-12-02       Impact factor: 9.162

Review 3.  Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.

Authors:  E J Limkin; R Sun; L Dercle; E I Zacharaki; C Robert; S Reuzé; A Schernberg; N Paragios; E Deutsch; C Ferté
Journal:  Ann Oncol       Date:  2017-06-01       Impact factor: 32.976

4.  An institutional review of clear cell chondrosarcoma.

Authors:  Ari Itälä; Taninnit Leerapun; Carrie Inwards; Mark Collins; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2005-11       Impact factor: 4.176

5.  Clear cell chondrosarcoma of bone.

Authors:  K S Ayoub; R J Grimer; S R Carter; D C Mangham; A M Davies; R M Tillman
Journal:  Sarcoma       Date:  1999

6.  Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature.

Authors:  Alexander Klein; Felix Tauscher; Christof Birkenmaier; Andrea Baur-Melnyk; Thomas Knösel; Volkmar Jansson; Hans Roland Dürr
Journal:  J Bone Oncol       Date:  2019-10-31       Impact factor: 4.072

7.  Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.

Authors:  S S Bielack; M C Cox; M Nathrath; K Apel; C Blattmann; T Holl; R Jenewein; U Klenk; P Klothaki; P Müller-Abt; S Ortega-Lawerenz; M Reynolds; M Scheer; K Simon-Klingenstein; S Stegmaier; R Tupper; C Vokuhl; T von Kalle
Journal:  Ann Oncol       Date:  2019-11-01       Impact factor: 32.976

8.  What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?

Authors:  Robert Nakayama; Keiko Hayakawa; Eisuke Kobayashi; Makoto Endo; Naofumi Asano; Tsukasa Yonemoto; Hiroyuki Kawashima; Kenichiro Hamada; Itsuo Watanabe; Hiroyuki Futani; Takahiro Goto; Yoshihiro Nishida; Toshifumi Ozaki
Journal:  Clin Orthop Relat Res       Date:  2020-11       Impact factor: 4.755
  8 in total
  1 in total

1.  Clear Cell Chondrosarcoma-Oncological Outcomes in an Asian Cohort.

Authors:  Ashish Gulia; Vineet Kurisunkal; Ajay Puri; Prakash Nayak; Bharat Rekhi
Journal:  Indian J Surg Oncol       Date:  2021-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.